Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?
2018 Feb 22;360:k587.
John H Powers
Scott R Evans
Aaron S Kesselheim
George Washington University School of Medicine, Washington, DC, USA.
Department of Biostatistics and the Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA.
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
No abstract available
Anti-Bacterial Agents / therapeutic use*
Bacterial Infections / drug therapy*
Drug Resistance, Multiple, Bacterial*
United States Food and Drug Administration